Old Web
English
Sign In
Acemap
>
authorDetail
>
Katie Koborsi
Katie Koborsi
Disease
Tolerability
Internal medicine
Dementia
Medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
2021
Journal of Alzheimer's Disease
Jonas Hannestad
Tiffanie Duclos
Whitney Chao
Katie Koborsi
Vicki Klutzaritz
Brian Beck
Ashok K. Patel
James Scott
Stephen G. Thein
Jeffrey L. Cummings
Gary Kay
Steven P. Braithwaite
Karoly Nikolich
Show All
Source
Cite
Save
Citations (1)
Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
2020
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Jonas Hannestad
Katie Koborsi
Vicki Klutzaritz
Whitney Chao
Rebecca Ray
Antonio Páez
Samuel J. Jackson
Scott Lohr
Jeffrey L. Cummings
Gary Kay
Karoly Nikolich
Steven P. Braithwaite
Show All
Source
Cite
Save
Citations (0)
RATIONALE AND DESIGN OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, DOSE-COMPARISON SAFETY AND TOLERABILITY STUDY OF GRF6019 IN MILD-TO-MODERATE ALZHEIMER’S DISEASE
2018
Alzheimers & Dementia
Jonas Hannestad
Darby Stephens
Katie Koborsi
Steven P. Braithwaite
Samuel Jackson
Show All
Source
Cite
Save
Citations (0)
1